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OBJECTIVES:  
 To determine the association of hyperhomocysteinemia with proliferative diabetic 
retinopathy  
METHODS:  
Patients with Type 2 diabetes mellitus underwent dilated fundus examination to diagnose and 
grade retinopathy. 39 patients with proliferative diabetic retinopathy (PDR) were enrolled as 
cases, and 39 age and gender matched patients with no retinopathy (No DR) were enrolled as 
controls, after obtaining informed consent. Baseline investigations (Hb, LDL, creatinine, 
HbA1c, fasting and post-prandial sugars) and fasting serum homocysteine estimation were 
done in all participants. Data regarding demographic profile and risk factors were 
documented. Data were analyzed using chi-square test, independent t test and Pearson 
correlation coefficient, as appropriate.  
RESULTS:  
The prevalence of hyperhomocysteinemia was higher in cases with PDR (59%) compared to 
controls with No DR (48.7%); however this difference was not statistically significant (p = 
0.36). The difference between the mean serum homocysteine levels between the cases and 
controls was not statistically significant (17.98 + 6.26 μmol/L vs. 17.71 + 8.17 μmol/L; p = 
0.87), although the mean homocysteine levels in both groups were higher than the upper limit 
of normal. Longer duration of diabetes, hypertension, anemia and renal dysfunction were 
found to be significantly associated with PDR. 
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